The challenge of finding the best patients for clinical trials became evident during the COVID-19 pandemic, when multiple pharma companies and CROs needed to recruit participants for vaccine trials as fast as possible. CRO services firm IQVIA stepped up to meet the challenge with an online matching tool dedicated specifically to matching patients with COVID-19 studies.

It’s just one example of emerging technologies designed to ease the process of recruiting patients for clinical trials. CROs that embrace these technologies could greatly improve the speed and efficiency of their trials.

We’ll explore the landscape of technologies and services that match patients to clinical trials, providing feedback from CRO executives who have experience with them.

Topics include:

  • How innovative technology is being harnessed to extract information from electronic medical records in order to identify the most appropriate patients for clinical trials.
  • Best practices for using social media to match patients to clinical trials.
  • Working with patient advocacy groups to incorporate clinical-trial matching technology into their member-facing websites and other communications platforms.

Featured Speakers

Dr Matt Wilson

CEO and Founder

Dr Matt Wilson is a former accident and emergency doctor, anesthetist and medical officer in the UK’s Royal Marines. He founded uMed in 2018, recognising the opportunity to automate key parts of the clinical study process by using electronic health record data. uMed is embedded across a rapidly expanding global network that includes over 2 million patients in more than 200 primary care sites in the UK and soon to include a number of US health systems.

Zoma Foster

Strategic Feasibility Manager

Zoma Foster has 10 years’ experience in clinical research with focus on feasibility and site identification. She is currently a Strategic Feasibility Manager at UCB, a global biopharmaceutical company. She supports various aspects of clinical trial planning globally in different therapeutic areas. She is passionate about ensuring that clinical trials are positioned for success with the optimal country footprint and ideal sites using a data-driven approach. Zoma is also core member of UCB’s team focused on driving diversity, equity and inclusiveness in clinical trials. She worked at large CROs prior to joining UCB.

Zoma holds a PhD in Biochemistry from the University of Houston. She also completed a postdoctoral fellowship with the Department of Pharmacological and Pharmaceutical Sciences at the University of Houston before joining the clinical research industry.

Ralph Passarella

CEO, Co-Founder
Reify Health

Ralph Passarella is the CEO and Co-Founder of Reify Health, where he and his team are working to accelerate the development of new, life-saving therapies. Through their work at Reify, Ralph and team also co-founded Signal Vine, an education technology company helping students navigate the administrative parts of higher education. Ralph currently serves on the Signal Vine Board of Directors. Prior to starting Reify Health, Ralph graduated from Vanderbilt University with a BA in Molecular and Cellular Biology and completed the first two years of the MD/PhD program at Johns Hopkins University School of Medicine.

Paulo Moreira

Global Head of Clinical Operations


Date:  Tuesday, October 5, 2021
Time:  11am ET / 8am PT
Duration:  1 Hour

Register now for this webinar